<DOC>
	<DOCNO>NCT02563769</DOCNO>
	<brief_summary>The main purpose study determine safe use study drug , clavulanic acid , combination cocaine . In study , subject receive intravenous ( i.v . ) cocaine study drug , clavulanic acid . The safety clavulanic acid study future study do find drug helpful treat cocaine dependence . Currently , available medication treatment cocaine dependence .</brief_summary>
	<brief_title>Clavulanic Acid ( CLAV ) Cocaine Interaction Safety Study</brief_title>
	<detailed_description />
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>Meet DSM5 criterion cocaine use disorder , moderate severe . Be nontreatment seek cocaine user . If female childbearing potential , must negative pregnancy test within 48 hour begin study willing use acceptable contraception abstinent 14 day prior study , entire study 30 day study participation . Be seek treatment substance abuse . Have physical dependence drug cocaine , nicotine caffeine , exception Alcohol Use Disorder mild severity . Have previous medically adverse reaction cocaine . Have previous medically adverse reaction clavulanic acid , Augmentin® , penicillin , Ticarcillin® , cephalosporin , betalactam drug . Have current lifetime history seizure seizure disorder . Have history heart disease , include coronary artery disease . ( For full inclusion/exclusion criterion information , please contact site directly . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Cocaine</keyword>
	<keyword>Clavulanic Acid</keyword>
</DOC>